Abstract
The influence of the 5-hydroxytryptamine1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (DPAT) on locomotor hyperactivity induced by the acute and chronic administration of cocaine was assessed. Horizontal activity was measured in the periphery and center of an open field test enclosure equipped with photobeams; vertical activity was also recorded. Peripheral hyperactivity induced by an acute administration of cocaine (10 or 20 mg/kg) was significantly enhanced by 0.2 mg/kg DPAT. In contrast, central and vertical activities were reduced in a dose-related manner by DPAT (0.1 and 0.2 mg/kg); DPAT also suppressed central (0.2 mg/kg) and vertical (0.1 and 0.2 mg/kg) activities when administered alone. Similar observations were made on day 1 of chronic treatment with DPAT (0, 0.1, or 0.2 mg/kg) injected 15 min before an injection of cocaine (0, 10, or 15 mg/kg) administered twice daily for 7 days. By day 7 of repeated DPAT treatment, sensitization of DPAT-evoked peripheral activity developed, which contrasted with tolerance to the central and vertical hypoactivity evoked by DPAT. Sensitization developed to the repeated treatment with 15 mg/kg cocaine but not 10 mg/kg cocaine. Interestingly, enhancements of all activity measures were observed between days 1 and 7 in rats cotreated with DPAT plus either dose of cocaine. This sensitization to DPAT plus cocaine was expressed on challenge with DPAT and cocaine but not with cocaine alone. The present study implies that the stimulation of 5-hydroxytryptamine1A receptors is capable of modulating the hyperactivity evoked by cocaine, possibly via modulation of the mesoaccumbens dopamine circuit thought to mediate the behavioral effects of cocaine.
Footnotes
-
Send reprint requests to: Dr. Kathryn A. Cunningham, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555-1031.
-
↵1 This work was supported by National Institute on Drug Abuse Grants DA05708, DA06511 (K.A.C.), and DA05638 (R.D.). Portions of this research were presented at the annual meeting of the Society for Neuroscience, Miami, FL, November, 1994, and at the annual meeting of the College on the Problems of Drug Dependence, Scottsdale, AZ, June, 1995. This research was presented to the Graduate School of the Biomedical Sciences at the University of Texas Medical Branch in partial fulfillment of the requirements for the degree of Doctor of Philosophy.
-
↵2 Present address: Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06520.
- Abbreviations:
- DA
- dopamine
- 5-HT
- 5-hydroxytryptamine (serotonin)
- COC
- cocaine
- SAL
- saline
- DPAT
- 8-hydroxy-2-(di-n-propylamino)tetralin
- NAc
- nucleus accumbens
- VTA
- ventral tegmental area
- Received February 3, 1999.
- Accepted September 13, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|